Show simple item record

dc.contributor.authorMartínez Eguiluz, Maitane
dc.contributor.authorArbelaiz Gallego, Olatz ORCID
dc.contributor.authorGurrutxaga Goikoetxea, Ibai ORCID
dc.contributor.authorMuguerza Rivero, Javier Francisco
dc.contributor.authorGómez Esteban, Juan Carlos
dc.contributor.authorGabilondo Cuellar, Iñigo
dc.contributor.authorMurueta-Goyena Larrañaga, Ane
dc.date.accessioned2024-09-27T16:53:56Z
dc.date.available2024-09-27T16:53:56Z
dc.date.issued2024-09-11
dc.identifier.citationApplied Sciences 14(18) : (2024) // Article ID 8149es_ES
dc.identifier.issn2076-3417
dc.identifier.urihttp://hdl.handle.net/10810/69591
dc.description.abstractParkinson’s disease (PD) is a neurodegenerative disorder marked by motor and cognitive impairments. The early prediction of cognitive deterioration in PD is crucial. This work aims to predict the change in the Montreal Cognitive Assessment (MoCA) at years 4 and 5 from baseline in the Parkinson’s Progression Markers Initiative database. The predictors included demographic and clinical variables: motor and non-motor symptoms from the baseline visit and change scores from baseline to the first-year follow-up. Various regression models were compared, and SHAP (SHapley Additive exPlanations) values were used to assess domain importance, while model coefficients evaluated variable importance. The LASSOLARS algorithm outperforms other models, achieving lowest the MAE, 1.55±0.23 and 1.56±0.19, for the fourth- and fifth-year predictions, respectively. Moreover, when trained to predict the average MoCA score change across both time points, its performance improved, reducing its MAE by 19%. Baseline MoCA scores and MoCA deterioration over the first-year were the most influential predictors of PD (highest model coefficients). However, the cumulative effect of other cognitive variables also contributed significantly. This study demonstrates that mid-term cognitive deterioration in PD can be accurately predicted from patients’ baseline cognitive performance and short-term cognitive deterioration, along with a few easily measurable clinical measurements.es_ES
dc.description.sponsorshipMaitane Martinez-Eguiluz is the recipient of a predoctoral fellowship from the Basque Government (Grant PRE-2022-1-0204). This work was funded by Grant PID2021-123087OB-I00, MICIU/AEI/10.13039/501100011033, and FEDER, UE (Grant Recipient: Olatz Arbelaitz and Javier Muguerza), as well as the Department of Economic Development and Competitiveness (ADIAN, IT1437-22) of the Basque Government (Grant Recipient: Javier Muguerza).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/PID2021-123087OB-I00es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/es/
dc.subjectParkinson’s diseasees_ES
dc.subjectmachine learninges_ES
dc.subjectcognitive deteriorationes_ES
dc.titleMachine Learning for Prediction of Cognitive Deterioration in Patients with Early Parkinson’s Diseasees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2024-09-27T13:19:26Z
dc.rights.holder© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/2076-3417/14/18/8149es_ES
dc.identifier.doi10.3390/app14188149
dc.departamentoesNeurociencias
dc.departamentoeuNeurozientziak


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).
Except where otherwise noted, this item's license is described as © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).